The Patent Finder

Dov Pharmaceutical, Inc.

Also on record
Records under this name other than patents Dov Pharmaceutical, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Dov Pharmaceutical, Inc.

PatentTitleStatus Expires Confidence
US 9,527,813Process for the Synthesis of (+) and (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]HEXANE
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,461,196Novel 1-aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
Formerly held
Term ended
Term ended Jul 25, 2026 · Medium confidence
Term endedTerm ended Jul 25, 2026Medium confidence
US 8,877,798Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
Formerly held
Term ended
Term ended Jul 25, 2026 · High confidence
Term endedTerm ended Jul 25, 2026High confidence
US 9,205,074Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
Formerly held
Term ended
Term ended Jul 25, 2026 · Medium confidence
Term endedTerm ended Jul 25, 2026Medium confidence
US 9,737,506Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
Formerly held
Term ended
Term ended Jul 25, 2026 · High confidence
Term endedTerm ended Jul 25, 2026High confidence
US 10,039,746Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
Formerly held
Term ended
Term ended Jul 25, 2026 · Medium confidence
Term endedTerm ended Jul 25, 2026Medium confidence
US 8,765,801Novel Polymorphs Of Azabicyclohexane
Formerly held
Term ended
Term ended Aug 16, 2025 · Medium confidence
Term endedTerm ended Aug 16, 2025Medium confidence
US 7,197,778Patient Transfer System
Formerly held
Term ended
Term ended Jun 28, 2024 · High confidence
Term endedTerm ended Jun 28, 2024High confidence
US 6,372,919(+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]HEXANE, Compositions Thereof, and Uses as an Anti-Depressant Agent
Formerly held
Term ended
Term ended Jan 11, 2021 · High confidence
Term endedTerm ended Jan 11, 2021High confidence
US 9,393,204Methods and Compositions Employing Bicifadine for Treating Disability or Functional Impairment Associated with Acute Pain, Chronic Pain, or Neuropathic Disorders
Lapsed on the fee record
Ended Jul 19, 2020 · Medium confidence
Lapsed on the fee recordEnded Jul 19, 2020Medium confidence
10 of 21 patents shown.
Pro members see all 21.
Pro members: see all 21 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited